AnimalhealthEurope

The most impactful simplification for the animal health sector is a clear, operational and sufficiently broad R&D exemption under the AI Act. The way it reads now (specifically developed and put into service for the sole purpose of scientific research and development) risks being interpreted too narrowly by competent authorities, potentially excluding AI systems or models used to research, design or optimise…

The most impactful simplification for the animal health sector is a clear, operational and sufficiently broad R&D exemption under the AI Act. The way it reads now (specifically developed and put into service for the sole purpose of scientific research and development) risks being interpreted too narrowly by competent authorities, potentially excluding AI systems or models used to research, design or optimise…

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products welcomes the possibility to provide feedback to the European Commission Proposal for a Regulation on the Digital Networks Act (DNA).

The Commission proposal includes some derogations for packaging used in medicines. AnimalhealthEurope welcome this recognition that the medicines and other health products sectors are of the most regulated in Europe and the world, and that our packaging (primary and secondary) plays a critical role in supporting the stability and storage and ensuring that animal patient safety and product effectiveness are not…

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products welcomes the possibility to provide feedback to the call for evidence on targeted updates and simplification of the EU rules on organic production. We believe that this initiative is a good opportunity to improve the health and welfare of animals raised in organic production.

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products welcomes the possibility to provide feedback to the call for evidence on targeted updates and simplification of the EU rules on organic production.

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products welcomes the possibility to provide feedback to the Proposal for a Regulation on establishing the European Competitiveness Fund ('ECF).

We welcome the possibility to provide feedback to this consultation. At the European Parliament level, we noticed some push from different political groups to include primary production. This said, and if option 3 will be chosen, Animal Health can be one of the most important allies to achieve the legally binding target of 10% for the primary production.

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products, welcomes the Commission Proposal on a European Biotech Act. AnimalhealthEuropes membership covers 90% of the European market for animal health products.

AnimalhealthEurope Feedback to the Commission Consultation on A European Biotech Act June 2025 AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products highly appreciates and welcomes the Commission intention to propose a new “European Biotech Act”.

Opening of the attached position paper · the full paper is on the Commission’s record (source link above)

AnimalhealthEurope is the voice of the animal health industry. Together we protect the health and welfare of over one billion animals across Europe, including both farm and companion animals. The veterinary sector not only protects animal health but also contributes to protect public health and to the production of safe, affordable and sustainable food.

While medicines are exempted from REACH, bans and restrictions on substances used in manufacturing can be prohibitive for the production of certain medicines or diagnostics as often no suitable alternatives are available.

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products, welcomes the Commissions intention to propose a European Biotech Act II. AnimalhealthEuropes membership covers 90% of the European market for animal health products.

AnimalhealthEurope welcomes the Commission commitments to simplify reporting and diminish administrative burden for companies operating in the European Union. AnimalhealthEurope applauds the initiative to rationalise and simplify reporting requirements for companies by at least 25%.

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products welcomes the possibility to provide feedback to the European Commission proposal for a Regulation on a framework of measures for strengthening the Unions semiconductor ecosystem, repealing Regulation (EU) 2023/1781 (Chips Act 2.0).

While medicines are exempted from REACH, bans and restrictions on substances used in manufacturing can be prohibitive for the production of certain medicines or diagnostics as often no suitable alternatives are available.

AnimalhealthEurope is the association representing manufacturers of animal medicines, vaccines and other animal health products in Europe. It represents both corporate members and national animal health associations.

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products welcomes the possibility to provide feedback to the call for evidence on a Vision 2040 for fisheries and aquaculture. Please find a more detailed feedback in the attachment.

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products welcomes the possibility to provide feedback on the evaluation of the Regulation 528/2012 on making available on the market and use of Biocidal Products (BPR).

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products, welcomes the possibility to provide feedback to the public consultation on the review of the National targets and flexibilities in the EU climate policy framework after 2030.

AnimalhealthEurope is the EU trade association representing manufacturers and developers of animal medicines, vaccines and other animal health products in Europe. It is essential that any action implemented through these legislations will not impact the availability, quality and supply of safe and efficacious medicines and vaccines for animals both in Europe and worldwide nor to inadvertently hinder innovation.

AnimalhealthEurope is the EU trade association representing manufacturers of animal medicines, vaccines and other animal health products in Europe. AnimalhealthEurope welcomes the objectives of this initiative with the goal to develop better access to chemicals data for safety assessments. In particular we support initiatives to compile publicly available information and assessments in a single resource.

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products welcomes the possibility to provide feedback to the call for evidence on the revision of the EU rules on the protection of marine environments. AnimalhealthEuropes membership covers 90% of the European market for animal health products.

AnimalhealthEurope represents the manufacturers of animal health products and services across Europe. The call for evidence refers to the “Fitness Check of all Chemicals Legislation” (COM(2019)264 final). We understand that the REACH Regulation, the pharmaceutical, veterinary and food additives legislations were excluded from the scope of this Fitness Check.

AnimalhealthEurope represents the manufacturers of animal health products and services across Europe. AnimalhealthEurope supports the need to revise the legal framework of ECHA to reflect the additional roles it has been given since its formation, to bring its procedures and working practices into line with the other agencies and to place its finances on a more sustainable footing.

AnimalhealthEurope welcomes the opportunity to provide feedback to the public consultations on the Welfare and traceability of dogs and cats and on Animal welfare protection of animals during transport. AnimalhealthEurope is the association representing manufacturers of animal medicines, vaccines and suppliers of other animal health products in Europe.

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products welcomes the Commission intention to simplify the implementation of the Common agricultural policy (CAP) strategic plans. The current CAP has proven to be very challenging to implement for farmers.

AnimalhealthEurope is the association representing the manufacturers of veterinary medicines, vaccines and other animal health products. AnimalhealthEuropes membership covers 90% of the European market for animal health products. Our membership includes both animal health companies and national associations, representing both innovators and generics alike, as well as large, medium-sized and small companies.

AnimalhealthEurope welcomes this opportunity to provide feedback to the call for evidence for an impact assessment on the Single Market Emergency Instrument initiative. As an industry we appreciate the multitude of benefits brought by the single market.

AnimalhealthEurope welcomes the opportunity to comment on this combined roadmap and inception impact assessment. In general we are in agreement with the document, particularly the intention to tackle the Non-authorised Feed Additives issue and the creation of new functional groups.

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products welcomes the possibility to provide feedback to the Proposal for a Regulation on the Union Civil Protection Mechanism and Union support for health emergency preparedness and response.

AnimalhealthEurope, the association representing the manufacturers of veterinary medicines, vaccines and other animal health products, welcomes the Commission Evaluation of the legislation on customs enforcement of intellectual property rights. AnimalhealthEuropes membership covers 90% of the European market for animal health products.

We welcome the recognition that EU action is therefore necessary to obtain comparable information about EU agriculture. This is particularly important for animal health data, which remains underrepresented despite its central role in sustainable farming, food safety, and animal welfare.

AnimalhealthEurope supports the appropriate funding of regulatory agencies essential to the efficient regulatory control of veterinary medicinal products (VMPs). However, the proposed cost-based system for EMA fees will be too expensive for the VMP sector. The EMA is being asked to expand its role, but this cannot and should not be funded by the VMP sector.

We welcome the opportunity to provide feedback. AnimalhealthEurope represents manufacturers of animal medicines, vaccines and suppliers of other animal health products in Europe. According to WOAH, approximately 75% of emerging human infectious diseases have been zoonotic. We consider that animal health has an essential role to play in controlling serious cross border threats.